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The Institute of  Virology, Vaccines and Sera Torlak was established in 1927, while the 
fi rst vaccine was produced in the Institute in 1930. Vaccines production implies using 
experimental animals, including mice, in in-process controls. The laboratory mice which 
have been in use in Torlak Institute from the very beginning belong to Swiss albino 
outbred stock. This stock, which has been in use for more than 80 years contains a large 
number of  mice maintained at all times, was recently named Intor:Swiss. Biological 
characteristics of  Intor:Swiss stock, are presented in this paper for the fi rst time. Taking 
into account the presented characteristics, the Institute Torlak`s Swiss mice are suitable 
for use in pharmaceutical studies, vaccine development research and basic research, 
as well as in toxicological studies. The publication of  data on the Intor:Swiss mice 
represents a contribution to the international scientifi c community, since it offers the 
possibility for obtaining an additional outbred mouse stock for research.
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INTRODUCTION
It is generally known that outbred mice are used in toxicology, pharmacology, 
fundamental biomedical research, and generally in biological research and applied 
studies. It has been calculated that in the period of  3.5 years (2002-2005), 33% of  
publications in which mice were used referred to outbred stocks [ 1]. This percentage 
did not include the unpublished commercial studies. Having in mind such a large 
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presence of  mice in research, it is very useful and important to know the characteristics 
of  different outbred stocks in as much detail as possible. 
Outbred colonies are genetically undefi ned; i.e. no two individual outbred mice 
from a population are the same. They are bred in a manner that allows maximum 
heterozygosity in the colony. When there is a need for a human population analogue 
in research, e.g recessive mutations that may affect experimental results, genetic 
background favours outbred mice. Further advantage of  using these stocks is that the 
mice are less expensive due to their relatively longer lifespan, heightened resistance to 
diseases, and higher fecundity with respect to the inbred strains. 
The most commonly used outbred mice stock is Swiss albino. However, Swiss mice 
from different sources may differ extensively because the long separation from the 
original stock. This is also the case with Swiss albino mice that have been bred in the 
Institute Torlak for more than 80 years. They have been used for toxicology studies 
during vaccines production and as general-purpose mice in many fi elds of  research. 
Biochemical, physiological, biological and immunological characteristics of  these mice 
have been well studied over time, which provided a solid basis for the data collected 
and presented in this paper. The biological properties presented herein provide a better 
insight into the possibility of  using the stock in different Torlak Institute studies, but 
also in other institutions focused on investigation of  diverse biological and biomedical 
phenomena. 
MATERIALS AND METHODS
Animals
Intor:Swiss laboratory mice described in this paper were bred in the Institute of  
Virology, Vaccines and Sera – Torlak. Male and female mice of  all ages were observed. 
One part of  the presented data (phenotype characteristics) was collected by observing 
the colony over many decades of  vaccine production control in the Institute. The 
second part of  the presented results (food consumption, body weight, relative organ 
weight, biochemistry, hematology and organ weights) was obtained from analysing 
the control group of  mice in the preclinical studies of  infl uenza vaccine, while the 
antibody subclasses analysis was performed on the sera of  experimental group of  
animals from the same study. Each group consisted of  minimum 50 male and 50 
female mice.
To get a lymphocyte profi le in the spleen we formed two additional groups, one with 
ten male and one with ten female mice, aged eight weeks. 
All experiments were carried out according to the rules established by the Serbian 
Animal Welfare Act and Regulation on the Implementation of  animal experiments 
and approved by the Animal Institutional Care and Use Committee at the Institute of  
Virology, Vaccines and Sera – Torlak. The approval for using laboratory animals in the 
infl uenza preclinical studies was adopted by the Veterinary Directorate (Ministry of  
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Agriculture and Environmental Protection) under the number: 323-06-03742/2012-
05.
All animals were kept in groups of  10 animals per cage and fed with standard food 
and water ad libitum in conventional conditions in the animal house. Humidity, 
temperature and light/dark cycles were maintained at 55% ±5%, 21 ±2 °C and 12/12 
h, respectively. Polygamous (5 + 1) mating system was applied in the colony.
Biochemical and hematological analysis
Determination of  biochemical values was performed using a semi-automated 
spectrophotometric analyzer (Vet evolution-Biosis, Italy) at the Department of  
Equine, Small Animal, Poultry and Wild Animal Diseases, of  the Faculty of  Veterinary 
Medicine in Belgrade. Blood required for biochemical tests was collected from the 
adult mice (~14 weeks) by intracardiac puncture method performed under deep 
anaesthesia induced as described above.
WBC, differential leukocyte and RBC counts were determined in-house. The blood 
samples for hematological analysis were taken from the tail vein. WBC count [2] was 
performed by making a suitable blood dilution in Turk`s solution (3% acetic acid 
in distilled water with 0.01% gentian violet) and then counted using a Neubauer 
hemocytometer. Differential white cell count test was done by preparing peripheral 
blood smears for each animal, after which the leukocyte formula was determined under 
light microscope. Smear preparations were fi xed in methanol for 2 min and stained for 
15 min. in May-Grunwald-Giemsa stain [3]. This consisted of  one drop Giemsa per 
milliliter McJunkin-Haden buffer at pH 6.4. One hundred leukocytes were counted 
under oil immersion and designated as either lymphocytes, monocytes, neutrophils, 
eosinophils or basophils, according to nuclear morphology described by Rygaard and 
Povlsen [4]. For RBC count [5], blood samples were diluted in Hayem’s solution (2.5% 
Na2SO4, 0.5% NaCl, 0.25% HgCl2) and erythrocytes were counted under the light 
microscope using the Neubauer haemocytometer [3].
Immunization and sera preparation
For the analysis of  antibody response, male mice (8–10 weeks old) were injected 
intramuscularly in each caudal thigh with either 50 l of  seasonal (composition of  2011–
2012 season) split virions (Sanofi -Pasteur, Lyon, France). The vaccine incorporated 
A/California/7/2009 (H1N1), A/Perth/16/2009(H3N2) and B/Brisbane/60/2008 
(B) infl uenza virus strains and contained 10 g (3.33 g of  each virus strain) of  the 
virus surface protein HA. 
The mice were bled from retro orbital sinus under ketamine–xylazine anesthesia 
(ketamine, 80 mg/kg Ketamidor, Richter Pharma AG, Wels, Austria; xylasine, 8 mg/kg 
Xylased, Bioveta, Ivanovice na Hané, Czech Republic) four weeks post immunization. 
The blood was allowed to clot for 1 h at room temperature. Sera were separated by 
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centrifugation at 3000 rpm for 30 min, heat-inactivated at 56 °C for 30 min and stored 
at −20 °C.
Indirect ELISA for the detection of infl uenza virion specifi c IgG isotype 
The sera samples were examined for infl uenza virus strain-specifi c IgG subclasses by 
ELISA [6]. Briefl y, split infl uenza virions used for coating ELISA plates were produced 
at the Institute of  Virology, Vaccines and Sera – Torlak, Belgrade. Nunc MaxiSorp™ 
ELISA plates (Nunc, Roskilde, Denmark) were covered (50 μl/well) with infl uenza 
split virions (2.5 μg/ml HA in PBS) by overnight adsorption (4 ºC). Blocking (200 
l/well of  1 % w/v BSA/PBS 2 h at room temperature) and all subsequent steps in 
the ELISA were followed by washing with 0.05 % (v/v) Tween 20 in PBS (four times, 
200 μl/well). Appropriately diluted (1:250 in 1 % w/v BSA in PBS) sera samples were 
incubated at room temperature (1 h, 50 μl/well).
Ag-specifi c sera IgG binding was detected by peroxidase-labeled anti-mouse IgG1, 
anti-mouse IgG2a, anti-mouse IgG2b and anti-mouse IgG3 (Jackson ImmunoResearch 
Laboratories Inc., WestGrove, PA, USA). Antibodies of  IgG2c subclass were detected 
by biotin-labeled anti-mouse IgG2c (Jackson ImmunoResearch Laboratories, West 
Grove, Pennsylvania, USA), followed by incubation with ExtrAvidin-peroxidase 
(50 μl/well, 1 h at room temperature). All reagents were used in accordance with 
the manufacturers’ instructions. O-phenylenediamine/H2O2 (OPD) system was used 
to visualize Ag–Ab interactions. Absorbance was monitored at 492 nm and 620 nm 
(A492/620). 
Detection of spleen lymphocytes subpopulations by fl ow cytometry
Spleens of  eight-week old Intor:Swiss mice were isolated, trimmed of  all excess 
tissue and macerated in a complete RPMI 1640 supplemented with 5 % fetal calf  
serum (FCS). The pellets obtained after centrifugation at 400xg for 10 min. were 
resuspended in residual supernatant and erythrocyte-depleted by incubation (1 min) in 
RBC-lysing buffer Red Blood Cell Lysing Buffer Hybri-Max™. After centrifugation 
at 400xg for 10 min, splenocytes were washed three times in 5 % FCS/RPMI 1640. 
The cells were fi nally diluted in 2% BSA/PBS with 0.1% sodium azide to 1x106 cells/
ml (hemocytometer counting). The lymphocyte population was analyzed by fl ow 
cytometry, using antibodies directed against CD3ε (145-2C11, Hamster IgG, FITC) 
and CD19 (PeCa1, Rat IgG2a, PE). Antibodies were purchased from Immunotools 
(Immunotools, Friesoythe, Germany) and were used at an amount of  4 μl per million 
cells. After incubation for 20 min (4 °C, dark), the cells were washed twice with 1 ml 
of  2% BSA/PBS/ 0.1% sodium azide vortexed and centrifuged at 400 x g for 10 min. 
Spleen lymphocytes populations were analyzed with FACVerse (Becton Dickinson, 
Mountain View, CA, USA), from a lymphocyte gate.
All chemicals were purchased from (Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany) unless otherwise indicated.
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RESULTS
Mice phenotype
Phenotypic characteristics of  Intor:Swiss albino mice in the Institute Torlak are similar 
to the phenotypic characteristics of  Swiss mice of  the commercial breeders (e.g. 
Crl:CFW [7], Crl:CD18, Hsd:ICR [8], and SW [9] mice). They have  short white fur and 
red eyes, moderately large ears and tail with little hair (Figure 1). Adult body length 
(nose to base of  tail) is 7.5–10 cm and tail length is about 5–10 cm. They have placid 
temperament, unless several males are in one cage. They manifest normal characteristics 
of  all categories of  common behaviors: a) maintenance behavior (grooming, eating, 
drinking, nesting); b) investigative/exploratory behavior (climbing, digging, chewing, 
sniffi ng); and c) social/sexual behavior (huddling together, grooming one another, 
scent/territorial marking, aggression, defense, sexual behavior and social interactions).
Reproductive and maternal characteristics of  the Intor:Swiss mice are excellent. Prior 
to and after giving birth, females particularly elaborate nests. Neonatal cannibalism, 
generally considered to be stress induced, and mortality rate among newborn litters are 
at an extremely low level. The rate of  “spontaneous” deaths in the colony is ~1.5%. 
These and other biological data for mice in our colony are given in the table below 
(Table 1).
Figure 1. Photograph of  an Intor:Swiss mice form the Institute of  
Virology, Vaccine and Sera – Torlak
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          Table 1. Main biological characteristics of  Intor:Swiss mice
Sexual maturity: 5 to 8 weeks
Breeding size: 30 g
Breeding age: 40-45 days (6-7 weeks)
Estrus cycle: 4 to 5 days; spontaneous
Gestation: 19– 21 days
Average litter size: 6-8 pups (primipara 4-6, multipara 9-11)
Birth weight: 0.9-1.5 g
Weaning weight 14 g
Adult weight 31-33 g (females), 34-40 g (males)
Time between two litters 30 days
Productive breeding life: ~7-8 months
Average lifespan 1.5-2 years
Serum biochemistry and hematology 
The standard biochemical and hematological parameters of  Intor:Swiss mice were 
determined from the serum and full blood collected from males and females, and are 
presented in the Tables 2 and 3, respectively.
Food consumption, body weight and relative organ weight
As relevant data used to describe laboratory mice, food consumption, body weight 
increase during growth, and relative organ weight of  adult individuals were determined. 
As much as measuring these parameters might seem trivial and unsophisticated, it has 
been shown in practice that they are very sensitive indicators of  general condition in 
mice, so we specify them for our mice.
Food consumption data were collected from groups of  mice which were controls in 
the preclinical studies of  infl uenza vaccine (groups of  50 female and 50 male mice). 
Measure of  food pellets was done every day during the experimental period of  40 days 
for each cage (ten mice per cage) and presented as average of  24-hour consumption 
for individual mice. For adult females average quantity was: 3.69 g ± 0.18 g, and for 
males 5.2 g ± 0.25 g. The same animals monitored for food consumption were also 
monitored for the body mass increase (Figure 2). 
Relative organ weight was determined as a percentage ratio between organ weight and 
body weight (Figure 3). The weight of  organs representative for toxicology studies was 
measured. These organs were: liver, lungs, heart, kidneys, thymus, spleen, brain, and 
testicles and ovaries. 
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Table 2. Biochemical parameters of  Intor:Swiss mice
Analyte Unit Males Females
Alanine Aminotransferase (ALT) U/I 77.5±4.8 72.6±5.2
Albumin (ALB) g/dl 3.3±0.3 3.4±0.3
Alkaline Phosphatase (ALP) U/I 112.7±9.3 136.4±12.3
Aspartate Aminotransferase (AST) U/I 92.6±4.6 103.84±7.5
Bilirubin (TBIL) mg/dl 0.269±0.03 0.3±0.03
Calcium (Ca) mg/dl 9.12±0.7 9±1
Chloride (Cl) mmol/l 117.6±2.9 118.7±3.8
Cholesterol (CHOL) mg/dl 88.8±3.5 100.4±5.8
Creatinine (CREAT) mg/dl 0.57±0.06 0.51±0.05 
Gamma-glutamyl transferase (GGT) U/I <5 U/I <5 U/I
Glucose (GLU) mg/dl 71.35±1 63.96±1
Phosphate (PHOS) mg/dl 8.7±0.9 9.16±0.7
Potassium (K) mmol/l 7.14±0.6 6.76±0.6
Protein (TP) g/dl 5.2±0.6 5.56±0.9
Sodium (Na) mmol/l 138.8±0.4 139.36±0.4
Triglycerides (TRIG) mg/dl 128.3±43.3 174.3±51.3
Urea (URE) mg/dl 15.4±5.2 12.94±2.4
Figure 2. Intor:Swiss mice growth curve. The results for male 
(-•-), and female mice (-■-) ± S.E. are presented. 
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Table 3. Hematological parameters of  Intor:Swiss mice
Males Females
Total WBC (count x106/ml) 16.02 ± 1.5 12.04 ± 1.2
Lymphocytes (%) 78.19 ± 4.3 78.19 ± 4.3
Monocytes (%) 5.96 ± 2.2 5.95 ± 2.2
Neutrophils (%) 11.01 ± 3.6 11.00 ± 3.6
Eosinophils (%) 4.61 ± 3.9 4.61 ± 3.9
Basophils (%) 0.03 ± 0.1 0.03 ± 0.1
RBC (count x109/ml) 9.67 ± 1.2 8.54 ± 1.4
IgG isotypes in Intor:Swiss mice after immunization 
with infl uenza split vaccine
Figures 5 and 6 shows the expression of  A H1N1 specifi c IgG2 antibodies after the 
immunisation of  Intor:Swiss mice with infl uenza vaccine. The antibodies of  all IgG2 
subclasses (IgG2a, IgG2b and IgG2c) were detected. IgG2a and IgG2b antibodies, 
with various production intensities, are found in all tested animals. On the other side, 
the production of  IgG2c antibodies was induced only in 10% of  mice. 
Similar results were obtained for all three tested viral antigens.
Figure 3. Intor:Swiss mice relative organ weight. Gray columns represent males, and white 
represent female mice. Plotted values represent the mean value ± S.D. 
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Lymphocyte subpopulations in Intor: Swiss mice spleen
We have determined the presence of  T and B lymphocytes in the spleen of  the ten 
non-immunized male and ten non-immunized female mice, and the results are shown 
on Figure 4.
Figure 5. Distribution different isotypes of  IgG2 antibodies specifi c for infl uenza antigens in 
group of  fi fty observed mice. The sera of  immunized animals were analyzed by ELISA and 
the graph shows the measured absorbance. A) – antibodies of  IgG2a isotype; B) – antibodies 
of  IgG2b isotype; C) – antibodies of  IgG2c isotype.
Figure 4. T and B lymphocytes in spleen of  male (gray columns) and female (white columns) 
Intor:Swiss mice. Analysis of   splenocytes was done by fl ow cytometry. Plotted values 
represent the mean value ± S.D. 
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DISCUSSION
As already mentioned, in the Institute of  Virology, Vaccines and Sera Torlak have used 
Swiss mice for a long time, probably from the 30’s of  the last century.  In order to 
make our stock known to the general scholarly public, we have registered the name of  
the stock in the Mouse Genome Informatics (MGI) database [10] and presented data 
that we have collected over time.
The story about origin of  Intor:Swiss mice is not precisely known. In general, all Swiss 
mice were named after Switzerland, the country of  their origin. They all descended 
from animals bred at the Centre Anticancereus Romand in Lausanne, at the beginning 
of  the 20th century. Most outbred mice have precisely that common origin. From 
Lausanne colonies, 2 males and 7 females were imported to the Rockefeller Institute 
for Medical Research in New York by Clara Lynch in 1926 [11]. These mice were 
the foundation for animals designated a s  Webster. Today’s commonly available non-
inbred Swiss stocks descend from Lynch’s original mice, more (Swiss Webster mice - 
Rockefeller) or less directly from Webster’s colonies (ICR mice, NIH Swiss mice) [12].
However, it is little known that Swiss mice from Lausanne actually originated from 
France, from a colony of  about 200 animals bred at the beginning of  the 20th century 
in the Pasteur Institute in Paris, from where they were transferred to Switzerland [1]. 
Unfortunately, there are no written data about the origin of  the breeding stock of  
the animals in the Institute Torlak. However, the fact is that a designated building for 
Figure 6. Elicited percentage of  IgG2 isotypes in every individual mice after infl uenza 
immunization.  White – antibodies of  IgG2c isotype; Light gray – antibodies of  IgG2b isotype; 
Dark gray – antibodies of  IgG2a isotype. represent female mice. Plotted values represent the 
mean value ± S.D. 
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breeding and keeping of  laboratory animals in Institute Torlak was constructed in 
1930, [13] and that Swiss mice have been continuously bred at the Institute ever since 
(or even earlier). At that time, the experts who took part in founding the Institute in 
Belgrade went to a study visit to the Pasteur Institute in Paris. Based on the statements 
of  senior colleagues, it is assumed that these experts were the ones who brought 
the mice from the Pasteur Institute breeding stock. If  that is true, the Swiss mice 
bred in Institute Torlak descend, to a large extent directly from the mice from Paris. 
Unfortunately, we could not fi nd any written evidence in Belgrade or Paris to support 
this statement, and without additional proof  we cannot exclude the possibility that 
Intor:Swiss mice originate from Lausanne.
A very important matter when breeding an outbred mice stock is maintaining a suffi cient 
level of  heterozygosity. Since the extent of  genetic variation depends on the previous 
history of  the breeding stock, it is interesting whether or not the heterozygosity of  the 
Intor:Swiss stock was preserved during the past 80 years of  breeding in Institute Torlak. 
This genetic variation can range from almost zero, when a closed colony has been 
maintained with small numbers of  animals for many generations, or has experienced 
any genetic bottleneck (such as being reduced to small numbers in one generation), to 
a level that we meet in populations of  wild mice [14]. The mouse stock maintained in 
the Institute Torlak has ha d a very large number of  animals throughout all these years 
since the Institute was established. The records of  the number of  laboratory animals 
date from 1961 and show that the colony size has been maintained at 2,000 to 5,000 
animals. The system of  random breeding has been applied all the time, not selecting 
the most closely related animals. Since the minimum number of  pairs required to 
maintain the maximum heterozygosity is 25 pairs, [1] we can freely assert that the mice 
maintained in Institute Torlak are an outbred and not a closed colony. Even in the 
period before the recording system was introduced, the number of  crossed pairs did 
not fall below the number of  25 (personal communication).
According to the literature, some level of  inbreeding is unavoidable, although it will be 
negligible in such large colonies. However, the extent of  the genetic variation will not 
be known without a specifi c genetic investigation [15]. Such genetic analyses of  outbred 
mice have only recently been established [14,16]. It appears that for outbred mice, a 
genetic profi le of  heterozygous markers needs to be established for each particular 
stock, and this genetic profi le needs to be monitored throughout the existence of  the 
colony [17]. Such characterization of  Intor:Swiss stock could open up the possibility 
of  participating in the project Mouse Genome Database (MGD), the international 
database resource for laboratory mice. This could also make it possible to use this 
stock for better understanding drug or vaccine effects on the body in a physiological or 
pathological condition [14,18]. In addition, it is possible that, by determining genome 
characteristics and comparing them with the MGD data base, the assumption about 
our stock being one branch in the genealogy tree of  commercially available outbred 
stocks would be confi rmed or rejected [11]. 
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Undoubtedly, despite the appropriate colony size and breeding method, certain selective 
pressure is exerted on the animals bred for generations in artifi cial conditions, i.e. 
animals in stock respond to any environmental changes that might occur. For example, 
mice from most outbred stocks weigh more than mice from inbred strains as a result 
of  elimination of  smaller animals born in the breeding colonies through generations. 
Similarly, the mouse colony in the Institute Torlak has fully adapted over several 
decades to the existing conditions and to an extent changed stock characteristics. This 
could result in that today’s stock characteristics deviate to a larger or smaller extent 
from the ancestral stock characteristics or from the earlier published data referring to 
the same colony. Therefore, new characterization of  Swiss mice and comparison with 
the commercial stocks are more than advisable. 
In this paper, we have described biological, biochemical and hematological characteristics 
of  Intor:Swiss mice. Comparing to the data available for commercial stocks, we did 
not record any signifi cant difference in any of  analyzed characteristics (morphology, 
growth curve, food consumption, reproductive characteristics, life span, WBC and 
RBC counts, leukocyte count, biochemical characteristics of  the serum). Although 
sporadic differences were noted, they were not statistically signifi cant. Barring all of  
the above in mind, we can conclude that Intor:Swiss stock has characteristics very 
similar to other outbred stocks, possibly originating from the same ancestral Swiss 
colony.
Given that the characteristics of  the immune system may become critical in the design 
of  certain preclinical studies, we have analyzed the presence of  T and B lymphocytes 
and profi les of  IgG subclasess (Figure 4, 5 i 6). It is already known that laboratory 
mice, including outbred stocks, [19,20] secrete IgG1, IgG2a, IgG2b and IgG3 isotypes 
in response to protein antigens. Genetic and structural analysis [21] of  the outbred 
Swiss Webster mice genes encoding constant region of  immunoglobulin subclasses 
have shown the presence and expression of  two allelic forms of  the Igh gene: Igh-1a 
allele, which codes IgG2a, and Igh-1b allele, coding IgG2c. IgG2b is coded by a separate 
gene, Igh-3 [22]. New papers [23] have shown that lymphocytes of  Swiss Webster 
mice may secrete, along with IgG2b, either only IgG2a or IgG2c, or both IgG2a and 
IgG2c subclasses. IgG2a and IgG2c most likely have different immune profi les in mice 
due to their divergence of  the protein sequence. After immunization with infl uenza 
vaccine, Intor:Swiss mice secrete virus specifi c antibodies of  IgG2a, IgG2b and IgG2c 
subclasses, which is another similarity between our and other outbred stocks. The 
production of  IgG2a and IgG2b subclasses was induced in all animals in the colony, 
but with different intensities. On the other hand, IgG2c antibodies were present in 
only 10% of  tested animals (Figure 5). Comparing the presence of  individual IgG 
subclasses in the analyzed sera (Figure 6), it is clear that IgG2a and IgG2c subclasses 
are mutually suppressed.
The results presented in this paper characterize the stock designated as Intor:Swiss and 
show that it is very similar to the standard commercial stocks. Taking that into account, 
and based on the extensive experience of  working with these mice in Institute Torlak, 
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we consider the Intor:Swiss stock suitable and reliable, for the experiments requiring 
mice of  outbred genetic background. 
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KARAKTERIZACIJA INTOR:SWISS SOJA ALBINO MIŠEVA 
DONETOG U INSTITUT ZA VIRUSOLOGIJU, VAKCINE I 
SERUME - TORLAK POČETKOM XX VEKA
ŽIVKOVIĆ Irena, RAJNPREHT Irena, MINIĆ Rajna, MITIĆ Katarina, ALEKSIĆ 
Iva, KADRIĆ Jasminka, PETRUŠIĆ Vladimir
Institut za Virusologiju, vakcine i serume Torlak, osnovan je 1927., a prva vakcina 
u Institutu proizvedena je 1930. Proizvodnja vakcina je složen proces koji između 
ostalog podrazumeva i korišćenje eksperimentalnih životinja u kontroli samog proc-
esa. Laboratorijski miševi koji su od samog početka bili u upotrebi u Institutu Torlak, 
pripadaju Swiss albino outbred soju. Ova kolonija je u upotrebi više od 80 godina i 
sve vreme se sastoji od velikog broja jedinki što omogućava očuvanje genetske razno-
likosti, pa samim tim i outbred karakteristika. Ovi miševi su odnedavno registrovani 
pod imenom Intor:Swiss, i njihove biološke osobine su u ovom radu prikazane po prvi 
put. Swiss miševi Instituta Torlak pogodni su za upotrebu u farmaceutskim studijama, 
za razvojno istraživanje vakcina, osnovna istraživanja i toksikološka ispitivanja. Zbog 
svega navedenog Intor:Swiss miševi predstavljaju još jedan pogodan animalni model 
za ispitivanje lekova i vakcina.
